Jonathan Melquist

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

38

H-Index

1

About

Dr. Jonathan Melquist is a urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for the treatment of urologic malignancies, particularly upper-tract urothelial carcinoma. His most-cited study, a 2015 comparison of single-docking robotic-assisted versus traditional laparoscopy for retroperitoneal lymph node dissection during nephroureterectomy, has garnered 38 citations and represents a pivotal contribution to the field. This work systematically evaluated the feasibility and perioperative outcomes of robotic surgery in a complex oncologic procedure, demonstrating comparable efficacy to laparoscopy while highlighting potential advantages in lymph node yield and surgical precision. Dr. Melquist’s research has helped refine surgical decision-making for patients with aggressive upper-tract tumors, offering evidence that robotic approaches can be safely integrated into standard practice. His findings have influenced clinical guidelines and sparked further investigation into robotic urologic oncology. Through this landmark study and related efforts, Dr. Melquist has established himself as a key voice in the evolution of robotic surgery, bridging the gap between technological innovation and patient-centered outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Single-docking Robotic-assisted and Traditional Laparoscopy for Retroperitoneal Lymph Node Dissection During Nephroureterectomy With Bladder Cuff Excision for Upper-tract Urothelial Carcinoma
38 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago